Armstrong Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2K Hold
437
﹤0.01% 502
2026
Q1
$37.9K Hold
437
﹤0.01% 457
2025
Q4
$42K Hold
437
﹤0.01% 423
2025
Q3
$41.6K Hold
437
﹤0.01% 426
2025
Q2
$38.1K Sell
437
-886
-67% -$75.1K ﹤0.01% 427
2025
Q1
$106K Hold
1,323
0.01% 268
2024
Q4
$106K Hold
1,323
0.01% 268
2024
Q3
$119K Sell
1,323
-16
-1% -$1.35K 0.01% 249
2024
Q2
$105K Sell
1,339
-148
-10% -$12.1K 0.01% 250
2024
Q1
$123K Hold
1,487
0.01% 224
2023
Q4
$123K Sell
1,487
-323
-18% -$24.6K 0.01% 224
2023
Q3
$142K Sell
1,810
-123
-6% -$10.3K 0.02% 196
2023
Q2
$170K Hold
1,933
0.02% 191
2023
Q1
$156K Hold
1,933
0.02% 188
2022
Q4
$150K Buy
+1,933
New +$157K 0.02% 192

Other funds holding MDT

Armstrong Advisory Group's MDT Position: Q2 2026 in Review

Armstrong Advisory Group held its Medtronic (MDT) position steady in Q2 2026 at 437 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

Armstrong Advisory Group first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $170K in Q2 2023. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Armstrong Advisory Group held 437 shares of Medtronic worth $34.2K as of Q2 2026.
  • Armstrong Advisory Group left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #502 holding.
  • Armstrong Advisory Group first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Medtronic position peaked at $170K in Q2 2023.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.